CCKBR and neoplasm: Hyperactivation of mTORC1 was reported in many human cancers, including CCKBR-positive primary MTC and lymph node metastases [12], whereas mTORC1 inhibition is known to reduce tumor angiogenesis and induce apoptosis as well as to enhance cancer sensitivity towards therapy-induced DNA damage [13].